PALO ALTO, Calif., Jan. 5, 2018 /PRNewswire-USNewswire/ -- ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor's study of its Paradise Renal Denervation System in people with hypertension, invo...
